Ibrutinib plus rituximab or chemoimmunotherapy for chronic lymphocytic leukemia
Chronic lymphocytic leukemia (CLL) is a type of cancer in which the bone marrow makes too many lymphocytes. Chemoimmunotherapy has been long used as a treatment of CLL, but recent studies suggest the ibrutinib–rituximab to be...